Famous Dave’s of America, Inc. (NASDAQ:DAVE) was recently included in a 13D filing by Gregory Bylinsky and Jefferson Gramm‘s Bandera Partners. According to the filing, Bandera currently owns a 7.8% activist position in Famous Daves of America, which contains 543,780 shares of the company. Bandera did not own shares of the company at the end of September 2015, according to its last 13F filing.
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
(Amendment No. 1)1
Famous Dave’s of America, Inc.
(Name of Issuer)
Common Stock, $0.01 par value
(Title of Class of Securities)
BANDERA PARTNERS LLC
50 Broad Street, Suite 1820
New York, New York 10004
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
January 20, 2016
(Date of Event Which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨.
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.
1 The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
Follow Famous Daves Of America Inc (NASDAQ:DAVE)Follow Famous Daves Of America Inc (NASDAQ:DAVE)
Biotech Stock Alert - 20% Guaranteed Return in One Year
Hedge Funds and Insiders Are Piling Into
One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.
Get your FREE REPORT and the details of our 20% return guarantee today.